Drugs / immunoglobulin antihepatitis B
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02862548 Comparator | Sep 2016 → Feb 2018 | chronic hepatitis B virus infection | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | immunoglobulin antihepatitis B | “Other approved antivirals (such as lamivudine, entecavir, or immunoglobulin antihepatitis B) administered per local practice” NCT02862548 ↗ |